13^th Annual Conference on Dementia and Alzheimers Disease December 13-15, 2018 Abu Dhabi, UAE

Max Tokarsky, Founder & CEO of InvestAcure, PBC Max is a lifelong social entrepreneur and non-profit executive. He is the Founder & CEO of InvestAcure, PBC, an SEC-registered RIA, with a bold plan to solve the current investment bottleneck at the clinical stage of Alzheimer's drug discovery. InvestAcure enables those impacted by Alzheimer's to partner in the search for a cure by automatically investing their spare in clinical stage pharmaceuticals spearheading research. This helps transition investment leadership from a narrow group of high-risk investors to a much larger and stable investment base, leading to more clinical trials, more drugs and drug combinations tested and progress to a cure

Alzheimer’s, Investment, Drug discovery, Eroom’s law

Dr. Shah is a geriatrician and director of Palliative Care at Broadlawns Medical Center (BMC). Dr. Shah’s areas of clinical expertise are Mild Cognitive Impairment (MCI) and palliative and hospice medicine. Dr. Shah earned his Geriatric Fellowship from the Mayo Clinic. He is triple-board-certified in Family Medicine, Geriatrics, Hospice and Palliative Care. In March 2013, he was awarded a Fulbright scholarship to develop a palliative care curriculum in Rwanda, Africa. Dr. Shah holds a Masters in Public Health (MPH) from Des Moines University. He has done noteworthy amount of work in the area of Social Determinates of Health (SDOH) in 50314 zip code in Des Moines, Iowa Dr. Shah has received numerous awards for his work related to aging and dementia. Recently he was awarded Iowa Juneteenth’s Health Practitioner Award and Preceptor of the Year Award by the Broadlawns Medical Center’s Residents. He received the Passport to Prosperity Award, which honors individuals who immigrated to the state of Iowa and have contributed significantly to the community.

Palliative Care

Emeritus Professor of Pharmacology, National University of Ireland, Honorary Professor,Depar­tment of Psychiatry and Psychotherapy, Ludwig Maximilian University, Munich, Germany

Neuro-and Psychopharmacology, Psychoneuroim­munology, Neuropsychiatric, Neurochemistry

Dr. Ghulam Md Ashraf is currently working as Associate Professor at King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia. Dr. Ashraf received his doctorate degree from Department of Biochemistry, Faculty of Life Sciences, Aligarh Muslim University, India. His current research work focuses primarily on the investigation of protein expression in cerebrospinal fluid and serum of neurological disorders. He is also interested in exploring the inherent connection of neurological disorders with other chronic diseases like cancer and diabetes by using proteomics and nanotechnological tools. Dr. Ashraf has published 133 research manuscripts in books and journals of international repute. Dr. Ashraf is involved in editorial capacity in many internationally reputed journals like Frontiers in Neuroscience, Scientific Reports, Protein & Peptide Letters and Journal of Proteomics, to mention a few.

Proteomics and Neurology